BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 17655275)

  • 1. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-mediated targeting of therapeutic and imaging agents to cancers.
    Reddy JA; Low PS
    Crit Rev Ther Drug Carrier Syst; 1998; 15(6):587-627. PubMed ID: 9883391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor detection using folate receptor-targeted imaging agents.
    Sega EI; Low PS
    Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug.
    Lu JY; Lowe DA; Kennedy MD; Low PS
    J Drug Target; 1999; 7(1):43-53. PubMed ID: 10614814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma.
    Turk MJ; Waters DJ; Low PS
    Cancer Lett; 2004 Sep; 213(2):165-72. PubMed ID: 15327831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues.
    Thomas M; Kularatne SA; Qi L; Kleindl P; Leamon CP; Hansen MJ; Low PS
    Ann N Y Acad Sci; 2009 Sep; 1175():32-9. PubMed ID: 19796075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploitation of the folate receptor in the management of cancer and inflammatory disease.
    Leamon CP; Jackman AL
    Vitam Horm; 2008; 79():203-33. PubMed ID: 18804696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
    Zhang Y; Guo L; Roeske RW; Antony AC; Jayaram HN
    Anal Biochem; 2004 Sep; 332(1):168-77. PubMed ID: 15301962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
    Lu Y; Sega E; Leamon CP; Low PS
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1161-76. PubMed ID: 15094213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-targeted non-viral DNA vectors for cancer gene therapy.
    Ward CM
    Curr Opin Mol Ther; 2000 Apr; 2(2):182-7. PubMed ID: 11249640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.
    Vlashi E; Sturgis JE; Thomas M; Low PS
    Mol Pharm; 2009; 6(6):1868-75. PubMed ID: 19754150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-targeted drug strategies for the treatment of cancer.
    Leamon CP
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1277-86. PubMed ID: 19037834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
    Juillerat-Jeanneret L; Schmitt F
    Med Res Rev; 2007 Jul; 27(4):574-90. PubMed ID: 17022028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Folate receptor-mediated antitumor drugs].
    Zhao J; Cao SL; Zheng XL; Zhao B
    Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
    Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
    J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.
    Garcia-Bennett A; Nees M; Fadeel B
    Biochem Pharmacol; 2011 Apr; 81(8):976-84. PubMed ID: 21300030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and grafting of folate-PEG-PAMAM conjugates onto quantum dots for selective targeting of folate-receptor-positive tumor cells.
    Zhao Y; Liu S; Li Y; Jiang W; Chang Y; Pan S; Fang X; Wang YA; Wang J
    J Colloid Interface Sci; 2010 Oct; 350(1):44-50. PubMed ID: 20624622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-targeted chemotherapy.
    Leamon CP; Reddy JA
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of nanoparticles: folate receptor.
    Kularatne SA; Low PS
    Methods Mol Biol; 2010; 624():249-65. PubMed ID: 20217601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.